Terms: = Colorectal cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
2063 results:
1. Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment.
Lu W; Wang Q; Liu L; Luo W
Sci Rep; 2024 May; 14(1):10883. PubMed ID: 38740818
[TBL] [Abstract] [Full Text] [Related]
2. cancer-derived exosomal lncRNA SNHG3 promotes the metastasis of colorectal cancer through hnRNPC-mediating RNA stability of β-catenin.
Huang L; Yang G; Shao Y; Sun J; Yang X; Hong H; Aikemu B; Yesseyeva G; Li S; Ding C; Fan X; Zhang S; Ma J; Zheng M
Int J Biol Sci; 2024; 20(7):2388-2402. PubMed ID: 38725844
[TBL] [Abstract] [Full Text] [Related]
3. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high.
Cai J; Yang Y; Zhang L; Fang Y; Zhang Y; Tan M; Zhang J; Tang C; Ren H; Wang L; Xiang G; Xu F; Lan L; Li L; Zheng X
BMC Cancer; 2024 May; 24(1):573. PubMed ID: 38724951
[TBL] [Abstract] [Full Text] [Related]
4. Modified Lichong decoction intervenes in colorectal cancer by modulating the intestinal flora and the Wnt/β-catenin signaling pathway.
Liu L; Zhao M; Lang X; Jia S; Kang X; Liu Y; Liu J
J Cancer Res Clin Oncol; 2024 May; 150(5):234. PubMed ID: 38710918
[TBL] [Abstract] [Full Text] [Related]
5. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation.
Yin Y; Yang X; Cheng Z; Wang H; Lei J; Wang D; Wang P; Li B; Mi J; Yuan Q
Front Immunol; 2024; 15():1371584. PubMed ID: 38694509
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract] [Full Text] [Related]
7. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in colorectal Carcinoma Cells.
Jacksi M; Schad E; Tantos A
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
[TBL] [Abstract] [Full Text] [Related]
8. Meroterpenoids from Marine Sponge
Wang J; Yan YL; Yu XY; Pan JY; Liu XL; Hong LL; Wang B
Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667800
[TBL] [Abstract] [Full Text] [Related]
9. The association between oxidized low-density lipoprotein and cancer: An emerging targeted therapeutic approach?
Moghadam SG; Ebrahimpour M; Alavizadeh SH; Kesharwani P; Sahebkar A
Bioorg Med Chem Lett; 2024 Jul; 106():129762. PubMed ID: 38649117
[TBL] [Abstract] [Full Text] [Related]
10. Establishment of a novel microfluidic co-culture system for simultaneous analysis of multiple indicators of gefitinib sensitivity in colorectal cancer cells.
Li X; Li W; Wang J; Wang Q; Liang M; Chen S; Ba W; Fang J
Mikrochim Acta; 2024 Apr; 191(5):279. PubMed ID: 38647729
[TBL] [Abstract] [Full Text] [Related]
11. Role of imbalanced gut microbiota in promoting CRC metastasis: from theory to clinical application.
Fan S; Zhou L; Zhang W; Wang D; Tang D
Cell Commun Signal; 2024 Apr; 22(1):232. PubMed ID: 38637851
[TBL] [Abstract] [Full Text] [Related]
12. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in colorectal cancer.
Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
[TBL] [Abstract] [Full Text] [Related]
13. The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of emt by CAFs.
Bogdanova DA; Kolosova ED; Pukhalskaia TV; Levchuk KA; Demidov ON; Belotserkovskaya EV
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612842
[TBL] [Abstract] [Full Text] [Related]
14. cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production.
Ghofrani-Shahpar M; Pakravan K; Razmara E; Amooie F; Mahmoudian M; Heshmati M; Babashah S
BMC Cancer; 2024 Apr; 24(1):400. PubMed ID: 38561726
[TBL] [Abstract] [Full Text] [Related]
15. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
[TBL] [Abstract] [Full Text] [Related]
16. Ethyl-acetate extract of Spatholobi Caulis blocked the pro-metastatic support from the hemato-microenvironment of colon cancer by specific disruption of tumor-platelet adhesion.
Sun L; Yang L; Du X; Liu L; Ran Q; Yang Q; Chen Y; Zhu X; Li Q
Phytomedicine; 2024 Jun; 128():155420. PubMed ID: 38547619
[TBL] [Abstract] [Full Text] [Related]
17. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer.
Rong Z; Zheng K; Chen J; Jin X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):154. PubMed ID: 38521878
[TBL] [Abstract] [Full Text] [Related]
18. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y
Gene; 2024 Jul; 914():148406. PubMed ID: 38521111
[TBL] [Abstract] [Full Text] [Related]
19. Bis-arylidene oxindoles for colorectal cancer nanotherapy.
Bhattacharyya T; Mishra T; Das D; Adhikari SS; Banerjee R
Bioorg Chem; 2024 May; 146():107294. PubMed ID: 38507997
[TBL] [Abstract] [Full Text] [Related]
20. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
[Next]
